Pharmerica Corporation (NYSE:PMC) was downgraded by BidaskClub from a “hold” rating to a “sell” rating in a research note issued to investors on Monday, July 31st.
A number of other research analysts have also recently commented on the stock. Zacks Investment Research raised shares of Pharmerica Corporation from a “hold” rating to a “buy” rating and set a $28.00 target price on the stock in a research report on Saturday, June 24th. ValuEngine lowered shares of Pharmerica Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $28.83.
Pharmerica Corporation (NYSE:PMC) remained flat at $29.05 on Monday. 497,567 shares of the company traded hands. The stock has a 50 day moving average price of $27.05 and a 200-day moving average price of $25.07. Pharmerica Corporation has a 52 week low of $19.20 and a 52 week high of $29.10. The stock has a market capitalization of $904.07 million, a P/E ratio of 39.36 and a beta of 0.92.
COPYRIGHT VIOLATION WARNING: “Pharmerica Corporation (NYSE:PMC) Downgraded to Sell at BidaskClub” was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.com-unik.info/2017/08/19/pharmerica-corporation-nysepmc-stock-rating-lowered-by-bidaskclub-updated-updated.html.
Several large investors have recently bought and sold shares of the stock. Russell Investments Group Ltd. increased its stake in Pharmerica Corporation by 124.5% in the second quarter. Russell Investments Group Ltd. now owns 4,886 shares of the company’s stock valued at $128,000 after buying an additional 2,710 shares during the last quarter. Public Employees Retirement System of Ohio boosted its stake in Pharmerica Corporation by 10.5% in the second quarter. Public Employees Retirement System of Ohio now owns 5,028 shares of the company’s stock worth $132,000 after buying an additional 476 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of Pharmerica Corporation during the first quarter worth about $121,000. State of Alaska Department of Revenue raised its stake in shares of Pharmerica Corporation by 79.8% in the second quarter. State of Alaska Department of Revenue now owns 6,112 shares of the company’s stock worth $160,000 after buying an additional 2,712 shares during the last quarter. Finally, US Bancorp DE raised its stake in shares of Pharmerica Corporation by 41.3% in the first quarter. US Bancorp DE now owns 7,121 shares of the company’s stock worth $167,000 after buying an additional 2,081 shares during the last quarter. 94.25% of the stock is owned by institutional investors and hedge funds.
About Pharmerica Corporation
What are top analysts saying about Pharmerica Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Pharmerica Corporation and related companies.